The University of Texas Health Science Center, Houston
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center, Houston sits in the top decile of US sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center, Houston: 732 sponsored US clinical trials, 144 recruiting.
The University of Texas Health Science Center, Houston sponsors 732 registered US clinical trials on ClinicalTrials.gov, 144 of them currently recruiting, and 436 completed. 98 of these trials are in Phase 3-4 (later-stage) and 139 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 8 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center, Houston ranks in the top decile of sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
436 of 521 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
732 total, page 9 of 15
(mo)BETTA Trial in Transwomen for Optimization of ART
NCT03348163
CytID Analysis of Oral Lesions
NCT03555721
Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
NCT03539887
The UTHealth Medical-Legal Partnership: Improving Health by Addressing Health-Harming Legal Needs
NCT03364543
Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV
NCT03329560
Robotic Versus Laparoscopic Ventral Hernia Repair
NCT03490266
N-of-1 Trials In Children With Hypertension
NCT03461003
MAST Trial: Multi-modal Analgesic Strategies in Trauma
NCT03472469
Restoring Hand Function Utilizing Nerve Transfers in Persons With Cervical Spinal Cord Injuries
NCT03451474
Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock
NCT03366220
Multidisciplinary Team Approach: Working Together to Improve Glycemic Control in Hispanic Adults Diabetes
NCT03463629
Self Transcranial Direct Current Stimulation for Pain in Older Adults With Knee Osteoarthritis
NCT03425019
Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation
NCT03458871
Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study
NCT03523767
Effect of D-amphetamine on Reward Functioning
NCT03369015
School Based Program to Prevent Teen Dating Violence
NCT02909673
Transpulmonary Pressures in Mechanical Ventilated Patients With Morbid Obesity
NCT02309190
Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
NCT03298048
Ibuprofen and Acetaminophen Versus Ibuprofen and Acetaminophen Plus Hydrocodone for Analgesia After Cesarean Section
NCT03372382
Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings
NCT03302741
MEditation for Post Stroke Depression
NCT03239132
A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants
NCT03298035
Use of Pediatric Size Phlebotomy Tubes in Adult Critically Ill Patients to Reduce Red Blood Cell Transfusions
NCT03286465
Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
NCT02611167
Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families
NCT04045964
Optical Elastography of Systemic Sclerosis Skin
NCT02835196
Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis
NCT03219840
Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children with Recurrent Posterior Fossa Brain Tumors
NCT02905110
A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation
NCT03292562
Management of Sub-Clinical Bacteriuria in Pregnancy
NCT03275623
Tissue Reinforcement of Incisional Closure Among High Risk Patients
NCT03148496
Effects of Transcutaneous Spinal Direct Current Stimulation in Incomplete Spinal Cord Injury
NCT03249454
Facilitating Treatment Entry and Family Planning in Substance-using Neonatal Intensive Care Unit (NICU) Mothers
NCT03165565
Thirdhand Smoke Contamination in a Neonatal Intensive Care Unit (NICU)
NCT04155697
CT and Radiologist RCT
NCT03121131
A Comparison of Custom-manufactured vs. Off-the-rack (OTR) Compression Hosiery for Initial Management of Venous Disease
NCT03630185
Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development
NCT02949726
Platelet Transfusion During Neonatal Open Heart Surgery
NCT03045068
Metabolomics for Biomarker Discovery in Children With EoE
NCT03107819
Mesh Type in Ventral Hernia Repair
NCT03091790
Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women
NCT03046355
Assessment of Ability of 3D Fluorscopy in Aiding Accurate Syndesmotic Reduction Following Traumatic Ankle Injury
NCT03163017
Combining tsDCS and Exoskeleton Gait Training on Spinal Excitability in SCI
NCT02862080
Clinical Algorithm for Post-Stroke Gait Training With C-Brace
NCT02892760
Detection of Area of Ischemia in Patients With Subacute Stroke Via a Hybrid EEG-fNIRS Brain-computer Interface
NCT03034902
Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Ependymoma
NCT02940483
Paracervical Block Versus No Paracervical Block During IUD Insertion
NCT02904915
Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention
NCT02896712
The UTHealth Ketamine Project
NCT02882711
Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 1
NCT06082505
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 84 |
| Phase 3 | 13 |
| Phase 4 | 85 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center, Houston pipeline
144 recruiting of 732 indexed (20% open); 436 completed (60%).
Phase mix: 98 late (III/IV) vs 139 early (I/II) (balanced across stages).
Top condition: Stroke (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center, Houston: open-pipeline peers nationwide
Peers matched on 732 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center, Houston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 732 trials (± recruiting share)
- University of Miami · 721 trials · 20% recruiting
- Sanofi · 713 trials · 10% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- University of Chicago · 20% recruiting · 796 trials
Related
What to do with this The University of Texas Health Science Center, Houston page
732 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center, Houston or any single study.
- 144 of The University of Texas Health Science Center, Houston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Health Science Center, Houston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center, Houston pipeline card: 732 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.